• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

David W. Parke II, MD, assumes AAO presidency

Article

David W. Parke II, MD, became the new president of the American Academy of Ophthalmology (AAO) Jan. 1, succeeding C.P. Wilkinson, MD.

San Francisco-David W. Parke II, MD, became the new president of the American Academy of Ophthalmology (AAO) Jan. 1, succeeding C.P. Wilkinson, MD.

"There has never been a more exciting time for ophthalmology, as medical advances give ophthalmologists breakthrough treatment options to save vision," said Dr. Parke, the Edward L. Gaylord Professor and chairman of the Department of Ophthalmology at the University of Oklahoma, Oklahoma City. "Ophthalmology is also faced with challenges ranging from Medicare reimbursement to scope of practice. I look forward to serving the [AAO] and its members in the year ahead."

Dr. Parke, also president and chief executive officer of the Dean A. McGee Eye Institute in Oklahoma City, has held numerous leadership positions in the AAO. He has served on the organization's board since 2000, first as trustee-at-large from 2000 to 2001 and subsequently as senior secretary for ophthalmic practice from 2002 to 2006.

"Few leaders come to this presidency post with this much experience and dedication to the [AAO] and the profession," said H. Dunbar Hoskins Jr., MD, the group's executive vice president. "We are thrilled to have Dr. Parke lead us through this year."

Dr. Parke received his medical degree from Baylor College of Medicine, Houston, and completed his residency there in 1981 at the Cullen Eye Institute, followed by a fellowship in medical retina and a subsequent fellowship in surgical retina.

His other active medical leadership positions include president of the AUPO and director of the American Board of Ophthalmology. He serves on multiple professional boards, including the Oklahoma Academy of Ophthalmology. He also is a member of the board of directors of Ophthalmic Mutual Insurance Co. and Medem Inc.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.